Evidence map›Paper›PMID 39808161›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025

Cancer Incidence in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)-The Onco-SOL Ancillary Study.

Humberto Parada, Ilir Agalliu, Daniela Sotres-Alvarez, Andrew F Olshan, Kelly R Evenson, Thomas E Rohan, Robert C Kaplan, Caroline A Thompson, Linda C Gallo, Frank J Penedo and 7 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cancer statistics for Hispanic/Latino people, 2026.CA: a cancer journal for clinicians
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Humberto ParadaDivision of Epidemiology and Biostatistics, School of Public Health, San Diego State University, San Diego, California.ORCID 0000-0001-6562-8577
Ilir AgalliuDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.ORCID 0000-0002-6248-5790
Daniela Sotres-AlvarezDepartment of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.ORCID 0000-0002-3226-6140
Andrew F OlshanDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.ORCID 0000-0001-9115-5128
Kelly R EvensonDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.ORCID 0000-0002-3720-5830
Thomas E RohanDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.ORCID 0000-0001-6897-4045
Robert C KaplanDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.ORCID 0000-0003-3271-801X
Caroline A ThompsonDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.ORCID 0000-0001-9990-9756
Linda C GalloDepartment of Psychology, San Diego State University, San Diego, California.ORCID 0000-0002-3678-5888
Frank J PenedoDepartments of Psychology and Medicine, University of Miami College of Arts and Sciences and Miller School of Medicine, Miami, Florida.ORCID 0000-0002-2780-0417
Jianwen CaiDepartment of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.ORCID 0000-0002-4945-6733
Sylvia Wassertheil-SmollerDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.ORCID 0000-0002-5447-4653
Bharat ThyagarajanDepartment of Laboratory Medicine & Pathology, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0001-6968-6985
Stefani N ThomasDepartment of Laboratory Medicine & Pathology, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0003-1679-5453
Olga L Garcia-BedoyaDepartment of Medicine, University of Illinois at Chicago, Chicago, Illinois.ORCID 0009-0009-9234-1489
Martha L DaviglusInstitute for Minority Health Research, University of Illinois at Chicago, Chicago, Illinois.ORCID 0000-0002-6791-8727
Gregory A TalaveraDepartment of Psychology, San Diego State University, San Diego, California.ORCID 0000-0001-5360-1107

Funding

The Research Infrastructure Core of SDSU HealthLINK Center for Transdisciplinary Health Disparities ResearchU54MD012397 · NIMHD · SAN DIEGO STATE UNIVERSITY · PI Kristen Jennifer Wells · 2018 to 2026
$39.0M
Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
Building Capacity and Infrastructure for Population Health and Health Disparities Research at San Diego State UniversityS21MD010690 · NIMHD · SAN DIEGO STATE UNIVERSITY · PI AYALA, GUADALUPE X, CASTILLO, JOSE E · 2016 to 2020
$10.0M
San Diego Resource Center for advancing Alzheimer's Research in Minority Seniors (ARMS)P30AG059299 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALISON AHERN MOORE · 2018 to 2026
$7.4M
TALENT Shared Resources CoreU54CA285115 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI James D Murphy · 2023 to 2026
$6.6M
Research Education CoreU54CA285117 · NCI · SAN DIEGO STATE UNIVERSITY · PI Humberto Parada · 2023 to 2026
$6.2M
Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United StatesU01CA259208 · NCI · YALE UNIVERSITY · PI ZHANG, XUEHONG · 2022 to 2025
$2.9M
Physical Activity, Sedentary Behavior, and Cancer Incidence in WomenR01CA227122 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI EVENSON, KELLY R. · 2019 to 2022
$2.7M
Red Blood Cell Polyunsaturated Fatty Acids and Breast Cancer Mortality in the Women's Healthy Eating and Living (WHEL) StudyK01CA234317 · NCI · SAN DIEGO STATE UNIVERSITY · PI PARADA, HUMBERTO · 2019 to 2023
$928k
HISPANIC COMMUNITY HEALTH STUDY-268065233N01HC065233 · HC · COORDINATING CENTER · PI CHAMBLESS, LLOYD E · 2006 to 2006
–
Breast Cancer Research Foundation (BCRF) BCRF-23-140National Cancer Institute (NCI) 5R01 CA227122National Heart, Lung, and Blood Institute (NHLBI) N01-HC65233NCI NIH HHS K01 CA234317NCI NIH HHS R01 CA227122NCI NIH HHS U01 CA259208NCI NIH HHS U54 CA285115NCI NIH HHS U54 CA285117NHGRI NIH HHS HHSN268201300003CNHLBI NIH HHS HHSN268201300003INHLBI NIH HHS N01 HC065233NHLBI NIH HHS N01 HC065234NHLBI NIH HHS N01 HC065235NHLBI NIH HHS N01 HC065236NHLBI NIH HHS N01 HC065237NIA NIH HHS P30 AG059299NIEHS NIH HHS P30 ES027792NIMHD NIH HHS S21 MD010690NIMHD NIH HHS U54 MD012397
6 · The paper itself

Abstract

backgroundFew studies have examined how cancer incidence varies by the country of origin among US Hispanic/Latino adults. In this study, we describe the incidence rates (IR) of cancer overall and for screen-detectable, tobacco-related, and obesity-related cancers among 16,415 participants in the Hispanic Community Health Study/Study of Latinos, an ongoing population-based cohort study of Hispanic/Latino adults from diverse backgrounds.

methodsCohort participant records were linked to the state cancer registries in New York, Florida, California, and Illinois to ascertain cancer incidence from baseline (2008-2011) through 2021. We estimated weighted age-adjusted IRs and age- and sex-adjusted HRs.

resultsOver a mean follow-up of 10.7 (SD = 2.0) years, 715 incident invasive cancers were diagnosed including 118 female breast, 102 prostate, and 79 bronchus and lung cancers. The IR of all cancers combined was 26.2 [95% confidence interval (CI), 22.6-30.2] per 10,000 (10K) person-years (py). The IRs were lowest among persons of Mexican descent [IR, 19.0 (95% CI, 15.0-24.1) per 10K py] and highest for those of Puerto Rican [IR, 36.6 (95% CI, 28.4-47.0) per 10K py] descent. Compared with those of Mexican descent, those of Puerto Rican, Cuban, and Dominican descent had higher hazards of cancer incidence; the incidence of obesity-related (HR, 2.37; 95% CI, 1.43-3.95) and tobacco-related (HR, 3.00; 95% CI, 1.58-5.71) cancers was also the highest among Puerto Ricans.

conclusionsCancer IRs varied by Hispanic/Latino heritage and were masked when Hispanics/Latinos were aggregated into a single group. IMPACT: Understanding disparities in cancer risk by Hispanic/Latino heritage may help tailor cancer prevention and control strategies.

Indexed as

Hispanic or LatinoNeoplasmsAdultAgedCohort StudiesFemaleHumansIncidenceMaleMiddle AgedRegistriesUnited States

Identifiers

PMID39808161
PMCPMC11968240

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.